Structural organization of the human PON1 gene

Genomics

Volumn 35, Issue 3, 1996, Pages 586-589

  Clendenning, James B ^a   Humbert, Richard ^a   Green, Eric D ^b   Wood, Christina ^a,c   Traver, David ^a,d   Furlong, Clement E ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLESTERASE; ORGANOPHOSPHATE INSECTICIDE;

ARTICLE; CORONARY ARTERY DISEASE; DNA FLANKING REGION; DNA LIBRARY; DNA SEQUENCE; ENZYME ACTIVITY; GENE LOCATION; GENE STRUCTURE; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTRON; POLYADENYLATION; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA;

EID: 0030217931     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.0401     Document Type: Article

References (19)

1. 1. Adkins, S., Gan, K. N., Mody, M., and La Du, B. N. (1993). Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 52: 599-608.
2. 2. Aldridge, W. N. (1953). An enzyme hydrolysing diethyl-p-nitrophenyl phosphate (E-600) and its identity with the A-esterase of mammalian sera. Biochem. J. 53: 117-124.
3. 3. Costa, L. G., McDonald, B. E., Murphy, S. D., Omenn, G. S., Richter, R. J., Motulsky, A. G., and Furlong, C. E. (1990). Serum paraoxonase and its influence on paraoxon and chlorpyrifos toxicity in rats. Toxicol. Appl. Pharmacol. 103: 66-76.
4. 4. Furlong, C. E., Richter, R. J., Seidel, S. L., Costa, L. G., and Motulsky, A. G. (1989). Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal. Biochem. 180: 242-247.
5. 5. Green, E. D., Braden, V. V., Fulton, R. S., Lim, R., Ueltzen, M. S., Peluso, D. C., Mohr-Tidwell, R. M., Idol, J. R., Smith, L. M., Chumakov, I., Paslier, D. L., Cohen, D., Featherstone, T., and Green, P. (1995). A human chromosome 7 yeast artificial chromosome (YAC) resource: Construction, characterization, and screening. Genomics 25: 170-183.
6. 6. Hassett, C., Richter, R. J., Humbert, R., Chapline, C., Crabb, J. W., Omiecinski, C. J., and Furlong, C. E. (1991). Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30: 10141-10149.
7. 7. Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., and Furlong, C. E. (1993). The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet. 3: 73-76.
8. 8. Knowlton, R. G., Cohen-Haguenauer, O., Van Cong, N., Frezal, J., Brown, V. A., Barker, D., Braman, J. C., Schumm, J. W., Tsui, L., Buchwald, M., and Donis-Keller, H. (1985). A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature 318: 380-382.
9. 9. Li, W.-F., Costa, L. G., and Furlong, C. E. (1993). Serum paraoxonase status: A major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health. 40: 337-346.
10. 10. Li, W.-F., Furlong, C. E., and Costa, L. G. (1995). Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76: 219-226.
11. 11. Mackness, M. I., and Walker, C. H. (1983). Partial purification and properties of sheep serum 'A'-esterases. Biochem. Pharmacol. 32: 2291-2296.
12. 12. Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., and La Du, B. N. (1996). Toxicological implications of the multiple paraoxonases (PONS), a multi-gene family. Toxicologist, 30(1, part 2): 57.
13. 13. Ruiz, J., Blanch'e, H., James, R. W., Garin, M. C., Vaisse, C., Charpenter, G., Cohen, N., Morabia, A., Passa, P., and Froguel, P. (1995). Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346: 869-872.
14. 14. Serrato, M., and Marian, A. J. (1995). A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest. 96: 3005-3008.
15. 15. Sorenson, R. C., Primo-Parmo, S. L., Camper, S. A., and La Du, B. N. (1995). The genetic mapping and gene structure of mouse paraoxonase/arylesterase. Genomics 30: 431-438.
16. 16. Sorenson, R. C., Primo-Parmo, S. L., Kuo, C. L., Adkins, S., Lockridge, O., and La Du, B. N. (1995). Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/ arylesterase. Proc. Natl. Acad. Sci. USA 92: 7187-7891.
17. 17. Watson, A. D., et al. (1995). Protective effect of high density lipoprotein associated paraoxonase, inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96: 2882-2891.
18. 18. White, R., Woodward, S., Leppert, M., O'Connell, P., Hoff, M., Herbst, J., Lalouel, J., Dean, M., and Vande Woude, G. (1985). A closely linked genetic marker for cystic fibrosis. Nature 318: 382-384.
19. 19. Zech, R., and Zurcher, K. (1974). Organophosphate splitting enzymes in different mammals. Comp. Biochem. Physiol. 48B: 427-433.